EDIT:NASDAQ
Editas Medicine Inc
$2.39
arrow_downward
-0.41%(-0.0099) 1D
Oct 26, 10:53:25 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.39
High
$2.44
Low
$2.36
Mkt. cap
367.07M
Avg. vol.
2.88M
Volume
336.18K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
Open
$2.39
High
$2.44
Low
$2.36
Mkt. cap
367.07M
Avg. vol.
2.88M
Volume
336.18K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Investing.com
·
30 minutes ago
Dow Jones pulls back to MA cluster near 52,400: Live levels
TradingView
·
40 minutes ago
U.S. stocks advance ahead of key tech earnings, Fed decision
Yahoo Finance
·
1 hour ago
Stock Market Today (Oct. 26, 2026): S&P 500 climbs as markets gear up for earnings, Fed decision
ChartMill
·
1 hour ago
S&P 500 Premarket Movers: Gainers and Losers Before the Open
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc